EGFL7 Antikörper (AA 24-273)
-
- Target Alle EGFL7 Antikörper anzeigen
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
-
Bindungsspezifität
- AA 24-273
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EGFL7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse polyclonal antibody raised against a full-length recombinant EGFL7.
- Sequenz
- YRPGRRVCAV RAHGDPVSES FVQRVYQPFL TTCDGHRACS TYRTIYRTAY RRSPGLAPAR PRYACCPGWK RTSGLPGACG AAICQPPCRN GGSCVQPGRC RCPAGWRGDT CQSDVDERSA RRGGCPQRCI NTAGSYWCQC WEGHSLSADG TLCVPKGGPP RVAPNPTGVD SAMKEEVQRL QSRVDLLEEK LQLVLAPLHS LASQALEHGL PDPGSLLVHS FQQLGRIDSL SEQISFLEEQ LGSCSCKKDS
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- EGFL7 (AAH12377.1, 24 a.a. ~ 273 a.a) full-length recombinant protein with GST tag.
- Top Product
- Discover our top product EGFL7 Primärantikörper
-
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 1-273) antibody
EGFL7 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 24-273) antibodyEGFL7 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2H6 unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 30-80) antibodyEGFL7 Reaktivität: Human, Maus, Ratte ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 24-273) antibodyEGFL7 Reaktivität: Human ELISA Wirt: Maus Monoclonal 3G1 unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 73-198) antibodyEGFL7 Reaktivität: Human ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 1-273) antibodyEGFL7 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (AA 24-100) antibodyEGFL7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-EGF-Like-Domain, Multiple 7 (EGFL7) (Internal Region) antibodyVerified EGFL7 Reaktivität: Human WB, ELISA Wirt: Ziege Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 50 % glycerol
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
- Target
- EGFL7 (EGF-Like-Domain, Multiple 7 (EGFL7))
- Andere Bezeichnung
- EGFL7 (EGFL7 Produkte)
- Synonyme
- egfl7 antikoerper, MGC53105 antikoerper, EGFL7 antikoerper, zgc:136669 antikoerper, zgc:152804 antikoerper, zneu1 antikoerper, xegfl7 antikoerper, MGC147423 antikoerper, VE-statin antikoerper, Zneu1 antikoerper, NEU1 antikoerper, RP11-251M1.2 antikoerper, VE-STATIN antikoerper, ZNEU1 antikoerper, EGF like domain multiple 7 S homeolog antikoerper, EGF like domain multiple 7 antikoerper, EGF-like-domain, multiple 7 antikoerper, EGF-like domain 7 antikoerper, egfl7.S antikoerper, EGFL7 antikoerper, egfl7 antikoerper, Egfl7 antikoerper
- Hintergrund
-
Full Gene Name: EGF-like-domain, multiple 7
Synonyms: MGC111117,RP11-251M1.2,VE-STATIN,ZNEU1 - Gen-ID
- 51162
-
